Clinical trialNCT05379972CompletedPhase 2Interventional

Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers

SponsorUniversity of Colorado, DenverEnrollment9Gastric CancerGastroEsophageal Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is an open-label, phase II study with a safety lead-in to assess the response rate of induction olaparib and stereotactic beam radiotherapy (SBRT) followed by combination olaparib/pembrolizumab in patients with metastatic gastric and GEJ cancers after at least one of therapy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Sunnie S Kim, MD
University of Colorado, Denver
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Colorado Health
Aurora, Colorado, United States
Uchealth Memorial Hospital Central
Colorado Spring, Colorado, United States
Uchealth Memorial Hospital North
Colorado Springs, Colorado, United States
Uchealth Highlands Ranch Hospital
Highlands Ranch, Colorado, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Olaparib →Pembrolizumab →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 12 Jan 2023
Primary completion: 24 Feb 2025
Completion: 22 Jan 2026
Last update posted: 5 Jun 2026
Registered enrollment: 9
Registry id: NCT05379972

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.